National and Kapodistrian University of Athens
Μελέτη της ανοσοϊστοχημικής έκφρασης της πρωτεΐνης HER-2/neu και του αυξητικού παράγοντα VEGF σε ιστολογικά παρασκευάσματα ασθενών με καρκίνο του παχέος εντέρου
Abstract
dc:descriptionIntroduction: Increased expression of HER-2 promotes tumor cell growth and migration. In breast cancer, HER-2 overexpression has proved to be an important prognostic and predictive factor as well as a target for monoclonal therapy. Moreover studies in breast cancer patients indicate that overexpression of HER-2 is associated with increased expression of the vascular endothelial growth factor (VEGF). The latter is one of the key mediators of pathological angiogenesis. The measurement of microvascular density (MVD) and the overexpression of VEGF have been reported in several tumors and have been associated with disease progression. In colorectal cancer the clinical utility of these markers remain controversial and only a limited number of studies have investigated their correlation. Aim: To examine the relationship between VEGF, HER-2 and MVD and their correlation with clinicopathological parameters and survival in colorectal cancer. Materials and methods: A total of 51 colorectal cancer patients who underwent resection with curative intent at our department were included in this study. HER-2 protein expression was evaluated from tissue samples from the primary tumor using a semiquantitative standardized immunohistochemical staining kit. Tumor MVD and VEGF were also determined immunohistochemically with the anti-CD34 and anti-VEGF antibodies, respectively.Results: Forty nine patients (96.1%) showed a barely immunostaining (1+), 2 (3.9%) were moderately (2+) and none was strongly positive (3+) for HER-2. Ninety percent (90%) of colorectal cases showed VEGF positivity and the mean value for the MVD was 7.4±2.2. The MVD in the VEGF positive group was significantly higher than that in the negative group (7.5 vs. 6.2, p<0.05). There was no apparent association between HER2/neu and VEGF expression as well as of both markers with clinicopathological parameters and survival.Conclusion: The expression of VEGF in colon cancer may be regulated by mechanisms different from HER-2 pathway. None of these markers proved to be useful in the clinical setting.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pappas, Apostolos
- Παππάς, Απόστολος
Subjects
dc:subject × 14- Καρκίνος παχέος εντέρου
- Ανοσοϊστοχημεία
- Υποδοχέας ανθρώπινου επιδερμικού αυξητικού παράγοντα τύπου 2
- Ενδοθηλιακός αγγειακός αυξητικός παράγοντας
- Αγγειογένεση
- Colon cancer
- Immunohistochemistry
- Human receptor epidermal growth factor 2
- Vascular endothelial growth factor (VEGF)
- Angiogenesis
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29535